Clinical Trials Browser

Phase 2 × INDUSTRY × CYH33 × Clear all

NCT05043922 2026-01-30

A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

Phase 2 Active not recruiting

Ovarian Neoplasms, Recurrence